RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market

Eli Lilly and Company (NYSE:LLY) is included among the 14 Best GARP Stocks to Buy According to Analysts. RBC Capital Initiates Eli Lilly (LLY), Cites Long-Term Leadership in Obesity Market On February 25, RBC Capital initiated coverage of Eli Lilly and Company (NYSE:LLY) with an Outperform rating and a $1,250 price target. The firm said Lilly’s obesity franchise is positioned to dominate the market through 2030. The analyst noted that investor sentiment remains broadly positive. At the same time, there “ ...